Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with squamous cell carcinoma (a type of cancer) of the nasopharynx (the upper part of the throat, behind the nose), confirmed by a biopsy, at a certain stage of advancement — either at stage T2b or higher, and/or where the cancer has spread to nearby lymph nodes
- People whose cancer type falls within WHO pathological types I, II, or III (a classification system used to describe the type of nasopharyngeal cancer cells) (confirm with trial site)
- People who are aged 18 or older
- People who have a good general level of physical functioning, rated 0 or 1 on a standard medical scale (meaning able to carry out normal daily activities with little or no limitation)
- People whose doctors expect them to live for at least 6 months
- People whose tumour has been assessed and measured before treatment begins
- People who are well-nourished and healthy enough physically to tolerate both radiation therapy and chemotherapy
Who may not be able to join:
- People whose cancer has spread to distant parts of the body (known as stage IVc, or distant metastasis)
- People where the cancer has come back only in the lymph nodes in the neck
- People who are currently participating in, or have previously participated in, another interventional clinical trial for cancer treatment
- People who have had another type of cancer (other than a certain type of skin cancer called non-melanoma skin cancer) within the past 5 years, or who have had a cancer that started in the head or neck region
- People who have an active infection that is currently untreated
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yuan Taize, private hospital
Phone: 8620-32506195
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of severe late complications
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.